“…LTB4 has been shown to impact the immune response and spread of viral infections, including those caused by HIV, respiratory syncytial virus, and Epstein-Barr virus (EBV) (44)(45)(46)(47)(48)(49). 5LO, LTA4H, and LTB4 are found at high levels in most of the inflammation and oxidative stress-associated cancers, such as breast, lung, prostate, pancreatic, colon, bladder, esophageal, and testicular cancers; glioma; chronic myelogenous leukemia; and Mantle cell lymphoma (MCL) non-Hodgkin's lymphomas (41,42,(50)(51)(52)(53)(54). 5LO pathway inhibitors have been tested as chemoprevention agents in many cancers (55,56).…”